Brain Tumor Treatment Satisfaction Survey

Brain Tumors Clinical Trial

Official title:

Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00557375
• Other study ID #: MHIRB 2007-036
• Status: Completed
• Start date: June 1, 2007
• Est. completion date: March 1, 2009

Study information

• Verified date: April 2022
• Source: Methodist Healthcare
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.

Description:

Patients with a recent diagnosis and treatment of a brain tumor (primary or metastatic; N=105, 61% female, 39% male) were identified in the clinics of Semmes-Murphey Neurologic and Spine Institute or the Methodist University Hospital in Memphis, TN. Caregivers were recruited from among relatives and friends who provide the most day-to-day care to the patient. All participants were between 3 months and 1 year from their most recent brain tumor treatment. Participants were given a simple, 5-point based survey to asses treatment-specific satisfaction, patient education, posttreatment quality of life, and pre- and post-treatment emotional impact. Therapeutic modalities surveyed include: surgery, external beam radiotherapy, whole-brain radiotherapy, stereotactic radiosurgery, and chemotherapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 105
• Est. completion date: March 1, 2009
• Est. primary completion date: March 1, 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients who are between 3 months and one year out from treatment for their brain tumor

• Karnofsky Performance Status (KPS) >= 60

• Age 18 years or over, any gender, any race

• "patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients

Exclusion Criteria:

• No exclusions

Related Conditions & MeSH terms

• Brain Neoplasms
• Brain Tumors

Locations

Country	Name	City	State
United States	Methodist University Hospital	Memphis	Tennessee

Sponsors (1)

Lead Sponsor	Collaborator
Methodist Healthcare

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors.		(greater than or equal to 3 months) from first treatment for brain tumor
Secondary	Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver.		(Greater than or equal to 3 months) from first treatment for brain tumor